Wentzel Parri, Eriksson Ulf J
Department of Medical Cell Biology, Uppsala University, Biomedical Center, Uppsala, Sweden.
Teratology. 2002 Oct;66(4):164-8. doi: 10.1002/tera.10068.
Diabetic pregnancy displays increased incidence of congenital malformations and elevated levels of lipid peroxides in the offspring. The aim of the present work was to study if exogenous administration of one lipid peroxide, the isoprostane 8-iso-PGF(2alpha), is teratogenic per se in rat embryos in vitro, and if such teratological effects may be diminished by supplementation of an antioxidative agent, i.e., N-acetylcysteine or superoxide dismutase, to the culture medium.
Day-9 embryos were cultured in vitro for 48 hr and subjected to 8-iso-PGF(2alpha) with and without N-acetylcysteine or superoxide dismutase.
Addition of 2 micromol/l of the isoprostane 8-iso-PGF(2alpha) to the culture medium caused high malformation rate, decreased protein and DNA contents, decreased somite number and crown-rump-length as well as marked accumulation of the isoprostane in the embryonic tissues. Adding N-acetylcysteine or superoxide dismutase to the culture medium with isoprostane normalized almost all morphological and biochemical parameters, including the elevated tissue concentration of 8-iso-PGF(2alpha).
Results indicate that the isoprostane (8-iso-PGF(2alpha)) serves both as an oxidative stress indicator and a teratogenic agent. The findings support earlier studies of enhanced oxidative stress and increased malformation rate in embryos exposed to a diabetes-like environment, and suggest prevention of dysmorphogenesis by administration of antioxidative agents.
糖尿病妊娠时,后代先天性畸形的发生率增加,脂质过氧化物水平升高。本研究的目的是探讨体外给予一种脂质过氧化物异前列腺素8-异前列腺素F2α(8-iso-PGF2α)本身是否对大鼠胚胎具有致畸性,以及向培养基中添加抗氧化剂(即N-乙酰半胱氨酸或超氧化物歧化酶)是否可减轻这种致畸作用。
将妊娠第9天的胚胎在体外培养48小时,并分别在添加和不添加N-乙酰半胱氨酸或超氧化物歧化酶的情况下给予8-iso-PGF2α。
向培养基中添加2微摩尔/升的异前列腺素8-iso-PGF2α会导致高畸形率、蛋白质和DNA含量降低、体节数和顶臀长度减少,以及胚胎组织中异前列腺素的明显积累。向含有异前列腺素的培养基中添加N-乙酰半胱氨酸或超氧化物歧化酶几乎使所有形态学和生化参数恢复正常,包括8-iso-PGF2α升高的组织浓度。
结果表明,异前列腺素(8-iso-PGF2α)既是氧化应激指标,也是致畸剂。这些发现支持了早期关于暴露于类似糖尿病环境的胚胎中氧化应激增强和畸形率增加的研究,并表明通过给予抗氧化剂可预防畸形发生。